Enfusion, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2021 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Enfusion, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2021 to Q4 2023.
  • Enfusion, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2023 was $3.4M, a 10.7% decline year-over-year.
  • Enfusion, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2023 was $7.46M, a 70.2% decline year-over-year.
  • Enfusion, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.46M, a 70.2% decline from 2022.
  • Enfusion, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $25M, a 91.4% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $7.46M $3.4M -$406K -10.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 $7.86M $2.56M +$1.73M +208% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $6.14M $2.64M -$5.03M -65.6% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $11.2M -$1.15M -$13.8M -109% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $25M $3.81M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 $833K +$833K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $7.67M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $12.7M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.